ClinConnect ClinConnect Logo
Search / Trial NCT04299685

Family Factors of Eating Habits Among Adolescents

Launched by THE UNIVERSITY OF HONG KONG · Mar 4, 2020

Trial Information

Current as of April 24, 2025

Completed

Keywords

Eating Habits, Barriers, Facilitators, Adolescents

ClinConnect Summary

Background:

Healthy lifestyle is a key preventive approach to combat the rising prevalence of non-communicable diseases (NCD) worldwide\], among which diet is highlighted as a modifiable risk factor of the most common NCD, namely hypertension, diabetes mellitus and coronary heart disease. Adolescence is a transitioning stage from parent-dependence to increasing autonomy in behavior including healthy or risky behavior. The dietary habit established in this period has high tendency to continue to adulthood.

Many national dietary recommendations were established to promote quality diet in or...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Family with an adolescent aged 10-19 by 31 December 2019
  • At least one adolescent from the family had completed dietary intake survey on or before 31 December 2019
  • Both parent and child have given written consent
  • Exclusion Criteria:
  • Parent or child cannot speak Cantonese
  • Neither parent is the primary caregiver of the child

Trial Officials

Cindy Lo Kuen Lam, MBBS

Principal Investigator

The University of Hong Kong

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials